S. Mandrekar

发表论文 350 篇 · 总被引 17065 次 · h-index 54

代表论文

• Long-term Follow-up from A041202 Shows Continued Efficacy of Ibrutinib Regimens for Older Adults with CLL. (2024 · Blood · 被引 40)
• Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer. (2026 · New England Journal of Medicine · 被引 18)
• Feasibility of Structuring Electronic Health Record Data to Facilitate Real-World Data Research: ICAREdata Methods Applied to Multicenter Cancer Clinical Trials (2024 · Cancer · 被引 9)
• 10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years (2024 · Blood · 被引 9)
• Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot (2024 · Cancer · 被引 6)
• Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy. (2025 · Journal of Clinical Oncology · 被引 3)